Monoacylglycerol lipases act as evolutionarily conserved regulators of non-oxidative ethanol metabolism
Current FDA concern The FDA says compounded AOD-9604 may carry immunogenicity risks for some routes and may have problems linked to peptide impurities and product characterization
Tan X, Chen R, Zhu S, Wang H, Yan D, Zhang X, et al
Complete the prescribed treatment course for the best therapeutic results
Cell cycle analysis The position of the cells in the cell cycle was determined by flow cytometric analysis of the DNA content using propidium iodide
Seven additional Phase 3 readouts are expected through the remainder of the year, covering applications in type 2 diabetes, obstructive sleep apnea, chronic low back pain, cardiovascular outcomes, and metabolic liver disease